(NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar ® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, ...

Naor was most recently CFO at surgical solutions company Axogen, Neuronetics said Monday. Naor previously held the top finance role at specialty pharmaceutical company Arbor Pharm ...

BTIG initiated coverage of Neuronetics Inc. STIM on Monday, noting that the company is entering a pivotal new phase as the ...

Revisit Neuronetics with updates on operations, financial performance, and outlook. Click to read how recent developments ...

Detailed price information for Neuronetics Inc (STIM-Q) from The Globe and Mail including charting and trades.

Neuronetics Inc. advanced stock charts by Barron's. View STIM historical stock data and compare to other stocks, and exchanges.

ABSTRACT: Background: Anxiety is common in people living with chronic breathlessness. Cranial Electrotherapy Stimulation (CES) with the Alpha-Stim Anxiety, Insomnia, Depression (AID) has evidence of ...

GlobalData forecasts that the global neurological devices market will reach a valuation of $20.9bn by 2033, up from $12.5bn in 2023. Image credit: ArtemisDiana via Shutterstock.com. The US Food and ...

Transcranial electrical stimulation (tES) was associated with reduced depressive symptoms in a new meta-analysis – but individual types of tES were linked to different outcomes. Transcranial direct ...

Neuros Medical announced today that it closed an oversubscribed Series D financing round worth $56 million in proceeds. Aliso Viejo, California-based Neuros plans to use the funds to support U.S.

When you buy through affiliate links in our content, we may earn a commission at no extra cost to you. Learn how our funding model works. By using this website you agree to our terms and conditions ...